bioAffinity Technologies, Inc.(Nasdaq: BIAF; BIAFW), a biotechnology company focused on noninvasive diagnostics and early cancer detection, today announced that its wholly owned laboratory subsidiary, Precision Pathology Laboratory Services (PPLS), has successfully maintained its accreditation from the College of American Pathologists (CAP) following a rigorous on-site inspection.
For the full article click here: bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation